» Articles » PMID: 11353613

Association of Amino Acid Substitutions in Penicillin-binding Protein 3 with Beta-lactam Resistance in Beta-lactamase-negative Ampicillin-resistant Haemophilus Influenzae

Overview
Specialty Pharmacology
Date 2001 May 17
PMID 11353613
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

The affinity of [(3)H]benzylpenicillin for penicillin-binding protein (PBP) 3A was reduced in 25 clinical isolates of beta-lactamase-negative ampicillin (AMP)-resistant (BLNAR) Haemophilus influenzae for which the AMP MIC was > or =1.0 microg/ml. The affinities of PBP 3B and PBP 4 were also reduced in some strains. The sequences of the ftsI gene encoding the transpeptidase domain of PBP 3A and/or PBP 3B and of the dacB gene encoding PBP 4 were determined for these strains and compared to those of AMP-susceptible Rd strains. The BLNAR strains were classified into three groups on the basis of deduced amino acid substitutions in the ftsI gene, which is thought to be involved in septal peptidoglycan synthesis. His-517, near the conserved Lys-Thr-Gly (KTG) motif, was substituted for Arg-517 in group I strains (n = 9), and Lys-526 was substituted for Asn-526 in group II strains (n = 12). In group III strains (n = 4), three residues (Met-377, Ser-385, and Leu-389), positioned near the conserved Ser-Ser-Asn (SSN) motif, were replaced with Ile, Thr, and Phe, respectively, in addition to the replacement with Lys-526. The MICs of cephem antibiotics with relatively high affinities for PBP 3A and PBP 3B were higher than those of AMP and meropenem for group III strains. The MICs of beta-lactams for H. influenzae transformants into which the ftsI gene from BLNAR strains was introduced were as high as those for the donors, and PBP 3A and PBP 3B showed decreased affinities for beta-lactams. There was no clear relationship between 7-bp deletions in the dacB gene and AMP susceptibility. Even though mutations in another gene(s) may be involved in beta-lactam resistance, these data indicate that mutations in the ftsI gene are the most important for development of resistance to beta-lactams in BLNAR strains.

Citing Articles

Epidemiology of invasive Haemophilus influenzae infections in Belgium: 2018-2022.

El Nouwar R, Prevost B, Wautier M, Yin N, Hites M, Martiny D Eur J Clin Microbiol Infect Dis. 2025; .

PMID: 39875613 DOI: 10.1007/s10096-025-05040-9.


Antibiotic resistance and molecular characterization of non-invasive clinical isolates in Germany 2019 and 2020.

Frank T, Wohlfarth E, Claus H, Krone M, Lam T, Kresken M JAC Antimicrob Resist. 2024; 6(6):dlae197.

PMID: 39659639 PMC: 11631347. DOI: 10.1093/jacamr/dlae197.


Revisiting mutational resistance to ampicillin and cefotaxime in Haemophilus influenzae.

Diricks M, Petersen S, Bartels L, Lam T, Claus H, Bajanca-Lavado M Genome Med. 2024; 16(1):140.

PMID: 39633433 PMC: 11616347. DOI: 10.1186/s13073-024-01406-4.


A Hunt for the Resistance of to Beta-Lactams.

Denizon M, Hong E, Terrade A, Taha M, Deghmane A Antibiotics (Basel). 2024; 13(8).

PMID: 39200061 PMC: 11352139. DOI: 10.3390/antibiotics13080761.


Monitoring of Haemophilus influenzae isolated from carriage, lower respiratory tract infections and blood over a six-month period in Belgium.

Wautier M, Unal S, Martiny D Eur J Clin Microbiol Infect Dis. 2024; 43(10):1919-1926.

PMID: 39042345 DOI: 10.1007/s10096-024-04900-0.


References
1.
Vega R, SADOFF H, Patterson M . Mechanisms of ampicillin resistance in Haemophilus influenzae type B. Antimicrob Agents Chemother. 1976; 9(1):164-8. PMC: 429493. DOI: 10.1128/AAC.9.1.164. View

2.
Asahi Y, Takeuchi Y, Ubukata K . Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates. Antimicrob Agents Chemother. 1999; 43(5):1252-5. PMC: 89251. DOI: 10.1128/AAC.43.5.1252. View

3.
Nakagawa J, Matsuhashi M . Molecular divergence of a major peptidoglycan synthetase with transglycosylase-transpeptidase activities in Escherichia coli --- penicillin-binding protein 1Bs. Biochem Biophys Res Commun. 1982; 105(4):1546-53. DOI: 10.1016/0006-291x(82)90964-0. View

4.
Parr Jr T, Bryan L . Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics. Antimicrob Agents Chemother. 1984; 25(6):747-53. PMC: 185634. DOI: 10.1128/AAC.25.6.747. View

5.
Mendelman P, Chaffin D, Stull T, Rubens C, Mack K, Smith A . Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother. 1984; 26(2):235-44. PMC: 284128. DOI: 10.1128/AAC.26.2.235. View